卓昇有限公司–最專業科學研究供應商
The non-keratinizing CERV-186 cell line was established in vitro from the xenotransplant cervix carcinoma MRI-H-186 by Cell Lines Service. Primary xenotransplant adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.
ABC-TC0130
CERV-186
Human
Tumor Cell Lines
1 vial
Dry Ice
Liquid Nitrogen
Accegen Biotechnology